Cargando…
Gut Microbial Disruption in Critically Ill Patients with COVID-19-Associated Pulmonary Aspergillosis
Objectives: COVID-19 disease can be exacerbated by Aspergillus superinfection (CAPA). However, the causes of CAPA are not yet fully understood. Recently, alterations in the gut microbiome have been associated with a more complicated and severe disease course in COVID-19 patients, most likely due to...
Autores principales: | Maurer, H. Carlo, Schult, David, Koyumdzhieva, Plamena, Reitmeier, Sandra, Middelhoff, Moritz, Rasch, Sebastian, List, Markus, Janssen, Klaus-Peter, Steiger, Katja, Protzer, Ulrike, Schmid, Roland M., Neuhaus, Klaus, Haller, Dirk, Quante, Michael, Lahmer, Tobias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787122/ https://www.ncbi.nlm.nih.gov/pubmed/36547598 http://dx.doi.org/10.3390/jof8121265 |
Ejemplares similares
-
Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19
por: Schult, David, et al.
Publicado: (2022) -
EASIX Is an Accurate and Easily Available Prognostic Score in Critically Ill Patients with Advanced Liver Disease
por: Schult, David, et al.
Publicado: (2023) -
Invasive pulmonary aspergillosis in severe coronavirus disease 2019 pneumonia
por: Lahmer, T., et al.
Publicado: (2020) -
Prevalence and outcome of invasive pulmonary aspergillosis in critically ill patients with liver cirrhosis: an observational study
por: Lahmer, Tobias, et al.
Publicado: (2019) -
Mucosal-Associated Invariant T (MAIT) Cells Are Highly Activated and Functionally Impaired in COVID-19 Patients
por: Deschler, Sebastian, et al.
Publicado: (2021)